AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Plays Down China ‘Origins’ Research Expectations 01/02/2021 Madeleine Hoecklin As the World Health Organization (WHO) led expert team on the origins of the SARS-CoV-2 virus began to conduct fieldwork at hospitals, research centers and markets in Wuhan, China, the WHO attempted to curb expectations, insisting that the mission will likely raise more questions. “The plans and the visits that they have, provide detailed information…The […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> Posts navigation Older postsNewer posts